Directed Learning eCourse


Share

Program Content

Activities

  • BTK Inhibitors in CLL/SLL and MCL
    Key Considerations for the Individualizing Use of BTK Inhibitors in B-Cell Malignancies
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 11, 2023

    Expires: October 10, 2024

Provided by

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca